FDA weighs saccharin ban after Canadian study links risk
FDA Commissioner Donald Kennedy extends saccharin public comment period to August 31 to review new Canadian evidence of human risk. Options discussed include restricting sales to prescription use or an outright ban, with over the counter availability in doubt.
MENTIONED IN THIS ARTICLE
Canada
Food and Drug Administration
Donald Kennedy
FDA
Kennedy
House Health Subcommittee
Paul Rogers
Dfla
Pneumonia-Like Illness Triggers CDC Tests
Nation and fever. Pneumonia set in and attending physicians noted many symptoms similar to the mysterious disease. Tests were sent to the national Center for Disease Con trol in Atlanta, and confirmation of the disease was received by state health officials Monday.
MENTIONED IN THIS ARTICLE
National Center For Disease Control
Atlanta
Monay
Also Mentioned on This Page
EDA
Canadas Saccharin News
Washington
NAACP
St. Louis
Carter
Sen
Thomas Eagleton
Margaret Bush Wilson
National Association For the Advancement of Colored People
Missouri
Eagleton
Richard C. Levy
Roger C. Langley
Levy
Langley
United States
Springfield
Philadelphia
Renfro
Illinois
Interiors
Drexel Heritage
President’s Trophy
General Agent & Associates
Broadway
Charleston
Mattoon
Mrs. Henderson
Carbondale Area
Larry Franklin
Massachusetts Mutual Life Insurance Company
Massachusetts
SYS
ZEBCO
Scumdesign
RADIO
Rts
Murphysboro
Mitchell
Notall
Peete
Kodak
Somata
Wark
Kestak
Ret
Thermos
Minolta Srt
Met Inc
Bend
Wholessie
Olemany
Frabill Deluxe